Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCI Private Wealth, LLC
Latest Disclosed Ownership550,867 shares
Latest Disclosed Value $ 190,039,620
CI Private Wealth, LLC reports 2.46% increase in ownership of AMGN / Amgen Inc.

On May 15, 2026 - CI Private Wealth, LLC filed a 13F-HR form disclosing ownership of 550,867 shares of Amgen Inc. (MX:AMGN) valued at $190,039,620 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 9, 2026 disclosing 537,630 shares of Amgen Inc.. This represents a change in shares of 2.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 550,867 13,237 2.46 190,040 7.98 0.2648
2026-03-09 2025-12-31 13F/A-1 AMGEN COM 031162100 537,630 188,531 54.01 176,000 81.31 0.2393
2026-02-19 2025-12-31 13F AMGEN COM 031162100 591,748 242,649 130,199 0.0490
2025-11-14 2025-09-30 13F AMGEN COM 031162100 349,099 -170,285 -32.79 97,074 -33.06 0.1530
2025-09-26 2025-06-30 13F/A-1 AMGEN COM 031162100 519,384 -11,477 -2.16 145,018 -12.32 0.1930
2025-08-15 2025-06-30 13F AMGEN COM 031162100 522,226 -8,635 145,884 0.1206
2025-05-14 2025-03-31 13F AMGEN COM 031162100 530,861 -33,239 -5.89 165,391 13.23 0.2701
2025-02-10 2024-12-31 13F AMGEN COM 031162100 564,100 -2,087 -0.37 146,065 -19.93 0.2424
2024-11-12 2024-09-30 13F AMGEN COM 031162100 566,187 -10,419 -1.81 182,431 1.26 0.2847
2024-08-13 2024-06-30 13F AMGEN COM 031162100 576,606 -299 -0.05 180,162 9.84 0.3138
2024-05-09 2024-03-31 13F AMGEN COM 031162100 576,905 -31,495 -5.18 164,023 -6.40 0.2920
2024-02-09 2023-12-31 13F AMGEN COM 031162100 608,400 35,217 6.14 175,231 13.75 0.3223
2023-11-03 2023-09-30 13F AMGEN COM 031162100 573,183 7,655 1.35 154,050 22.69 0.3540
2023-08-10 2023-06-30 13F AMGEN COM 031162100 565,528 154,879 37.72 125,561 26.48 0.2897
2023-05-15 2023-03-31 13F AMGEN COM 031162100 410,649 214,168 109.00 99,277 92.25 0.2666
2023-02-15 2022-12-31 13F AMGEN COM 031162100 196,481 196,481 51,640 0.1876
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.